| MATERIAL AND ME THODS
The protocol was reviewed and approved by the Royal Canin Internal Ethics Committee.
| Study population
The experiment was conducted at a commercial breeding kennel. All so that a stable temperature of 28-30°C at the ground level was assured. None of the whelpings were assisted, no caesarean section was performed, and no puppies were hand reared during the experiment. Puppies could suckle the dam freely. Lactating bitches and their puppies were fed ad libitum with the same diet, a dry expanded complete diet balanced for growing dogs (Starter, Royal Canin, Aimargues, France).
Each puppy was identified by a coloured woolen collar and its sex, breed, and the age of its dam were recorded. Puppies were weighed at birth, at 2, 3, 4, 7, 14, 21, and 28 days of age. Growth rate over the first 2 days of life was then calculated using the following equation: (weight at 2 days of life -weight at birth/weight at birth).
One millilitre of blood was collected into a plain tube from each puppy from the jugular vein at 2 and at 28 days of age. Samples were immediately centrifuged (3000 × g, 15 min) and serum was stored at −20°C until assayed.
Mortality over the first 4 weeks after birth was recorded.
Puppies remained unvaccinated against CPV2 until the end of the experiment. The circulation of CPV2 within the breeding kennel during the experimental period was demonstrated previously (Mila et al., 2014) .
| Immunoglobulin G assay
IgG concentration in serum was evaluated by a commercial ELISA test following the manufacturer's instructions (Dog IgG-Quantitation Kit, Bethyl Lab, Montgomery, USA; Mila et al., 2014) . Serum samples were thawed and diluted 1:50,000 and 1:100,000. Intra and inter assay coefficients of variation were 5.0% and 12.6%, respectively. A serum IgG at 2 days of age below 2.3 g/L was considered to characterize a deficit of passive immune transfer in puppies (Mila et al., 2014) .
| CPV2 antibodies assay
Titers of antibodies directed against CPV2 were evaluated on serum by haemagglutination inhibition test (HI) as previously described (Decaro et al., 2004) . Tests were performed at +4°C using 10 haemagglutinating units of CPV2 antigen and 1% pig erythrocytes.
Twofold dilutions in phosphate buffered saline (PBS) of each serum sample starting from 1:10 were tested and the HI titer was the highest serum dilution completely inhibiting viral haemagglutination.
Titers below 1:160 were considered as non-protective against CPV2 infection (Pollock & Carmichael, 1982) . Seroconversion was defined as a minimum fourfold increase of HI titer. = 11.3 [3.6; 37.7] ). The optimal cutoff value of growth rate within the first 48 hours of life to assess predictive likelihood of a IgG < 2.3 g/L was −2.7% with a sensitivity of 96.2% and a specificity of 83.1% (AUC = 0.94; J = 0.79; Figure 3 ; Table 1 ). Among puppies whose growth rate was below −2.7%, Growth rate (%)
| Statistical analysis

| RE SULTS
Postnatal day n=169 n =144 n=140 n=138 n =134 n=132 n =132 n=151 F I G U R E 2 Serum IgG concentration in puppies at 2 and at 28 days of life (Day 2 n = 151, black bars; Day 28 n = 127, grey bars) F I G U R E 3 Receiver operating characteristic (ROC) curves of growth rate within the first 48 hr of life depending on serum IgG concentration (interrupted line) or canine parvovirus type 2-specific maternally derived antibody titer (continuous line) at Day 2 (n = 151) and specificity of 88.4% (AUC = 0.92; J = 0.76; Figure 3 ; Table 1 ).
Among puppies with growth rate <−2.7%, 70.8% (34/48) had CPV2 
| D ISCUSS I ON
At birth, puppies are almost completely agammaglobulinaemic.
Subsequently, an important increase in IgG concentration is observed within the first 24-48 hr, with values ranging between 17.2 and 33.7 g/L (Bouchard et al., 1992; Poffenbarger et al., 1991; Schäfer-Somi, Bär-Schadler, & Aurich, 2005) . During the following 2 weeks, an important decrease is observed (2.2 g/L at Day 14), followed by a plateau until 4 weeks of age (2.5 g/L at Day 28) (Poffenbarger et al., 1991 ). An overall 6.8-fold decrease over the first month of life in serum IgG concentration was observed in the study of Poffenbarger et al. (1991) . Although the IgG concentration right after the colostrum intake was lower in our study (6.1 g/L at
Day 2), similar IgG evolution was observed, with a mean decrease of IgG concentration of a 4.5 ratio during the first 4 weeks after birth.
The difference in raw IgG concentrations might be explained by a higher number of included puppies (151 in the present study versus
in Poffenbarger et al.), and a different technique for immunoglobulin assay (ELISA test versus radial immunodiffusion assay).
Generally, the kinetics of the specific maternally derived antibodies (exemplified in our study by serum CPV2-specific MDA titer) in growing puppies is considered as similar to that of the IgG concentration (Day, 2007) . Nevertheless, a progressive decrease, rather than the plateau described by Poffenbarger et al. (1991) was described for serum CPV2-specific MDA titer by Pollock and Carmichael (1982) : puppies presented a twofold dilution per week in the HI test (MDA CPV2 titer of 1:160 at 4 weeks of age). When the titer achieves 1:80 or below, puppies become susceptible to CPV2 infection usually manifested as a severe gastroenteritis (Decaro et al., 2005) . In our study, CPV2 MDA showed a similar kinetics from birth, with a titer decrease from 1:320 at Day 2 to 1:40 at Day 28.
Whereas CPV2 MDA was of 1:160 at 4 weeks of age for Pollock and Carmichael (1982) , only 12% of puppies in our study had still a titer at or above 1:160 at this age. Nonetheless, none of the puppies presented any clinical signs of gastroenteritis over the study period, suggesting the presence of other than colostral antibodies sources of immune protection. Especially, the role of lactogenic immunity in the local protection against CPV2 infection needs further investigation.
We evidenced a positive correlation between serum IgG concentration and MDA titer in puppies at Day 2. Furthermore, in 12% of puppies, general and specific immune status was non-concordant, a high IgG concentration being accompanied by a low MDA titer or conversely, a high MDA titer being associated with a low IgG concentration (Table 2 ). Such a difference between the general and the specific passive immune transfer could be either due to a different concentration of specific immunoglobulins in the provided colostrum or due to different patterns of IgG and CPV2 antibodies uptake in the gut of newborn dog. Indeed, a large variability in colostrum IgG concentration was evidenced, not only among bitches but also among mammary glands of the same bitch .
Various inter-teat distribution of the FcRn receptor in the mammary gland tissue, receptor responsible for the IgG transport from the bloodstream to the mammary secretion, could explain such a high variability. Perhaps, the proportion of different subclasses of IgG in the colostrum differs from the proportion in the serum of the female, suggesting higher affinity of some IgG subclasses to the FcRn F I G U R E 6 Correlation between serum IgG concentration and log10 of canine parvovirus type 2-specific maternally derived antibody titer in puppies at 2 days of age (n = 151; ρ = 0.71; p < 0.001) TA B L E 2 Association between puppies' status regarding general (IgG) and specific (CPV2 -specific) passive immune transfer (n = 151). Serum IgG concentration at Day 2 below 2.3 ng/ml defined a deficit in general immunity (Mila et al., 2014) ; serum CPV2-specific antibody titer below 1:160 characterized a deficit in CPV2-specific immunity (Pollock & Carmichael, 1982) F I G U R E 7 Correlation between serum IgG concentration and log10 of canine parvovirus type 2-specific maternally derived antibody titer in puppies at 28 days of age (n = 125; ρ = 0.14; p = 0.11) (Garty, Ludomirsky, Danon, Peter, & Douglas, 1994) . For instance, antibodies specific for streptococci from group B are mainly from IgG2, subclass less transported via FcRn, and thus less efficiently transferred to the newborn baby (Taslmi, Sibai, Mason, & Dacus, 1986) . To date, the affinity of CPV2-specific antibodies with the FcRn remains unknown in canines.
Non-selective, rather than FcRn dependent mechanism of the immunoglobulin absorption from the gut was demonstrated in newborn kittens, with IgG transcytosis through the enterocytes (Baintner, 2007) . Relationship between the immunoglobulin concentration and specific antibody titer in the colostrum, as well as the mechanism of immunoglobulin transport from the mammary gland to the mammary secretion and from the newborn gut to its bloodstream needs further investigation in the canine species.
At 2 days of age, almost one out of five puppies included in our study suffered from a deficit of the passive immune transfer (IgG < 2.3 g/L). This prevalence, as well as the evidenced threshold value of IgG at Day 2 of life, remains to be evaluated in other kennels, with other environmental and epidemiological situations. As only one study, conducted in the same kennel, described the prevalence of the IgG deficit (Mila et al., 2014) , comparison of our result with other field situation is impossible to date. Nevertheless, in farm animals, percentage of newborns suffering from a deficit of passive immune transfer is of similar value: 19% in calves (Beam et al., 2009 ), 17% in lambs (Bekele, Otesile, & Kasali, 1992) , and 20% in foals (Perryman & McGuire, 1980) .
As in other species born agammaglobulinaemic, the adequate passive immune transfer appears to be essential for the puppies survival during the neonatal period (Mila et al., 2014) , but also later on during the weaning period. Puppies in deficit of MDA at birth become highly susceptible to infectious agents, such as CPV2.
Although the lactogenic immunity may play an important role in the protection against CPV2 infection, the MDA level has a strong impact on the clinical manifestation of the disease. In experimental conditions, puppies with different CPV2 MDA titers were inoculated with CPV2. Lower was the MDA titer at the time of inoculation, more severe were the clinical signs observed in puppies (Decaro et al., 2005) . Therefore, it seems important to provide puppies with the optimal level of specific immunity at birth. The growth rate over the first 48 hr of life was proposed in our study to discriminate puppies with an IgG deficit (IgG < 2.3 g/L)
and at the non-protective level of CPV2-specific passive immunity (CPV2 MDA < 1:160) at 2 days of life. 
| CON CLUS IONS
This study demonstrated a difference in the transfer of the spe- 
ACK N OWLED G M ENTS
We thank the owner of the kennel for his contribution to this work and Amélie Mugnier for helping in statistical data presentation. The present study was partially funded by Royal Canin SAS (Aimargues, France) (grant no. R3789 1/02/2012).
CO N FLI C T O F I NTE R E S T
None of the authors have any conflict of interest to declare. 
AUTH O R CO NTR
